Moderna Inc. (Cambridge, Mass.) proposed terms for an IPO in which it would raise about $500 million. If the mRNA company succeeds, the deal would be the largest ever on NASDAQ for a precommercial biotech.
The company is seeking to sell 21.7 million shares at $22-$24, according to an amended prospectus filed Nov. 28. At the